The path analysis showed that defense mechanisms are not directly involved in predicting the quality of life in patients with coronary heart disease. This finding is consistent with previous studies in different groups (
13,
14,
16). According to similar studies, defense mechanisms indirectly effect QOL in the patients towards certain psychological mediators. It has been discussed that defense mechanisms indirectly effect QOL in patients with CHD, through factors such as social support and other personality traits (
14,
16). In fact, mature defense mechanisms are important for making good social relationships and better quality of life (
38). Moreover, immature defense mechanisms reduce health-related QOL in patients with CHD, indirectly through increasing psychological distress, including depression, anxiety, and stress (
13,
16). According to the path analysis, defense mechanisms are not involved in predicting QOL in patients with CHD, indirectly through psychological distress. In the absence of similar studies, this finding is inconsistent with previous studies on other groups (
13,
14,
17). In explaining this finding, it can be stated that patients with heart disease are more exposed to stressful events because of the use of maladaptive coping styles and immature defense mechanisms that facilitate traumatic effects of anxiety (
13). In addition, it can be argued that using maladaptive defense mechanisms against life problems is directly related to psychological distress, as an unfavorable underpinning for deteriorated QOL (
14). As a result, the continuous use of immature and neurotic defense mechanisms increase emotional problems and have negative effects on QOL (
17,
38). The difference in research methods, and social, and cultural formulation of factors are associated with CHD in the studied populations and are of major reasons for the inconsistency of the findings of the present study with previous studies. Furthermore, the findings showed that defense mechanisms are indirectly involved in predicting the QOL in patients with CHD through alexithymia. To explain this new and important finding, alexithymia, as lack of emotional experiences, is considered as a maladaptive coping mechanism that is total denial of emotions and feelings to protect the self against emotional distress and extremely traumatic events (
39). Therefore, people with neurotic and immature defense mechanisms generally encounter stressful situations through denial, revocation or neglect, such as patients with alexithymia that deny distress (
40). Moreover, alexithymia can be considered as the inability in managing debilitating emotions as the main function of defense mechanisms (
41). In addition, defense mechanisms act to manage debilitating emotions and it can be stated that creation, escalation or adjusting alexithymia are other ways of indirectly effecting defense mechanisms and QOL in patients with CHD. In fact, defense mechanisms reduce QOL in patients through decreasing emotional regulation. In addition, the results showed that alexithymia is indirectly involved in predicting QOL in patients with CHD with the mediating role of psychological distress. These findings are consistent with previous studies (
7,
15,
20,
41). To explain these findings, it has been argued that alexithymia increases misconceptions of the patients about their disease and results in deteriorated of QOL (
41). Furthermore, patients with alexithymia, because of deficits in the cognitive processing of emotions, have exaggerated distress and worsened QOL. Consistent with previous findings (
39,
42), in this study alexithymia is indirectly involved in predicting QOL in patients with CHD via psychological distress. In explaining these findings, it should be noted that patients with alexithymia cannot understand their feelings and emotions and thus did not express them. In addition, it has been discussed that alexithymia negatively effects health-related QOL in patients with heart disease through somatization of psychological distress or enhancing the patients’ physical symptoms (
43,
44).
Limitations of the study were the lack of control of disease severity, the use of the convenience sampling method, time-consuming instruments, and limited statistical population. Therefore, the results should be used cautiously when generalized for patients with CHD in other circumstances. Therefore, study of the role of defense mechanisms and alexithymia in patients with CHD in other samples and other types of heart diseases is recommended. It is also suggested to use qualitative-quantitative and longitudinal designs in future studies by considering the role of other underlying personality traits in health-related QOL in patients with heart disease.